Willowcroft Pharm Inc

DENVER, CO · Founded 2009 · CIK 0001605460 · Biotech · Private

Pharmaceutical treatment for equine disease targeting the second leading cause of death in horses

willowcroftpharm.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$5.0M
1 Form D · Apr 2014
150 months since last filing
Contracts
—
No federal contracts on record
Patents
1
1 granted · 0 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$5,000,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1215MADRIGAL PHARMACEUTICALS, INC.—$35M
1216OS Therapies Inc—$30M
1217Universal Ibogaine Inc.—$135K
1218Willowcroft Pharm Inc—$5.0M
1219Valanbio Therapeutics Inc—$121K
1220IMMUNOQ THERAPEUTICS INC.——
1221Aegle Therapeutics Corp—$6.7M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 1 related persons
  • Charles OwenExecutive Officer

Patents

USPTO · 1 granted of 1

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.